Cite
Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
MLA
Dhruva, Sanket S., et al. “Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).” Hypertension (0194911X), vol. 70, no. 1, July 2017, pp. 94–102. EBSCOhost, https://doi.org/10.1161/HYPERTENSIONAHA.117.09221.
APA
Dhruva, S. S., Chenxi Huang, Spatz, E. S., Coppi, A. C., Warner, F., Shu-Xia Li, Haiqun Lin, Xiao Xu, Furberg, C. D., Davis, B. R., Pressel, S. L., Coifman, R. R., Krumholz, H. M., Huang, C., Li, S.-X., Lin, H., & Xu, X. (2017). Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). Hypertension (0194911X), 70(1), 94–102. https://doi.org/10.1161/HYPERTENSIONAHA.117.09221
Chicago
Dhruva, Sanket S., Chenxi Huang, Erica S. Spatz, Andreas C. Coppi, Frederick Warner, Shu-Xia Li, Haiqun Lin, et al. 2017. “Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).” Hypertension (0194911X) 70 (1): 94–102. doi:10.1161/HYPERTENSIONAHA.117.09221.